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Background: The current study sought to investigate the safety of intraoperative and early postoperative
continuous hyperthermic intraperitoneal perfusion (IEPCHIP) at different temperatures in a swine model of
experimental distal gastrectomy with Billroth II reconstruction.
Methods: Thirty pigs were randomly divided into 5 groups. Two groups were used as the control groups (groups
A1 and A2), and 3 groups were used as the perfusion groups (groups B, C and D). Pigs in group A1 received distal
gastrectomy with Billroth II reconstruction only. Pigs in groups A2, B, C and D received the same surgery as group
A1, followed by IEPCHIP at 37 ± 0.5°C, 42.5 ± 0.5°C, 43.5 ± 0.5°C or 44.5 ± 0.5°C, respectively. The perfusion time was
assessed for each pig in group A2 as well as in the perfusion groups, and the perfusions were performed twice for
each group. The first perfusion was conducted intraoperatively, and the second perfusion was initiated 1 day after
surgery. Data concerning vital signs and hepatic and renal function were collected. Parameters concerning
anastomotic healing, the pathology of the anastomotic tissue and abdominal adhesion were compared.
Results: The vital signs and hepatic and renal functions of the pigs in groups A1, A2, B and C were not significantly
affected by this procedure. In contrast, the vital signs and hepatic and renal functions of the pigs in group D were
significantly affected. Compared to the pigs in groups A1, A2 or B, the anastomotic bursting pressure, breaking
strength and hydroxyproline content in group C and D pigs were significantly lower. No significant differences
were observed in these parameters between groups A1, A2 and B. Abdominal adhesion was more severe in group
D pigs. Collagen deposition in group A1, A2 and B pigs was dense in the anastomosis, and inflammatory cell
infiltration was observed in group D.
Conclusions: IEPCHIP at 42.5 ± 0.5°C was safe and caused minimal impairments. However, anastomotic healing
was affected by perfusion at 43.5 ± 0.5°C and 44.5 ± 0.5°C, and abdominal adhesion was most severe in the group D
animals, which were perfused at 44.5 ± 0.5°C.
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More than 900,000 new cases of gastric cancer are
diagnosed worldwide each year, and 42% of these cases
occur in China [1]. In addition, more than 30% of
advanced gastric cancers coexist with peritoneal disse-
mination, and the median survival time for these patients
is approximately 6 months [2,3].
Even after radical gastrectomy, more than 50% of pa-
tients with advanced gastric cancer may die of peritoneal
recurrence [3,4]. In recent years, the improved survival
associated with hyperthermic intraperitoneal perfusion
chemotherapy for peritoneal carcinomatosis of gastric
cancer [5,6] has been verified by both experimental [7]
and clinical research [5,8]. Moreover, cytoreductive sur-
gery plus hyperthermic intraperitoneal perfusion chemo-
therapy has become the priority treatment for gastric
cancers with peritoneal carcinomatosis [9], and survival
can be prolonged by intraoperative and early postoperative
intraperitoneal chemotherapy [10,11]. This treatment may
result in the timely elimination of free cancer cells resul-
ting from operative factors or spontaneous dissemination.
Thus, hyperthermic intraperitoneal perfusion is consi-
dered effective for preventing and/or treating peritoneal
carcinomatosis and promoting survival [5,12].
However, hyperthermic intraperitoneal perfusion che-
motherapy increases perioperative complications and
mortality in cases of advanced gastric cancer [13-18].
The morbidity and mortality rates from 1999 to 2010
were between 12% and 66.3% and between 0% and
12.5%, respectively [3].
Early perfusion is thought to lead to an added increase
in the risk of postoperative complications and mortality.
Accordingly, the safety of early hyperthermic perfusion
has become an issue of importance. Anastomotic repair,
following reconstruction of the digestive tract, is consi-
dered one of the most crucial factors involved in post-
operative safety. When anastomotic malunion leads to
leakage, it may trigger abdominal infection, adhesive
bowel obstructions, anastomotic stricture and even sep-
tic shock [14-16]. Although reduced life quality should
not be a reason to deny this therapy [19], some investi-
gators believe that hyperthermia plus chemotherapeutics
affect wound healing [20]. Furthermore, hyperthermic
intraperitoneal perfusion chemotherapy after gastrointes-
tinal surgery does increase the likelihood of anastomotic
leakage and perioperative mortality [17,21].
Generally, cancer cells are effectively eliminated by
hyperthermic perfusion if the temperature exceeds 42°C
[22,23], although hyperthermia greater than 45°C leads to
irreversible hepatocyte damage [24]. Klaver and coworkers
examined adjuvant treatment after cytoreductive surgery
for peritoneal carcinomatosis in a rat model, and their
investigations of hyperthermic intraperitoneal perfusion at
37 or 41°C require further study [25].Moreover, few studies have been performed to examine
the safe and optimal temperature range for intraoperative
and early postoperative continuous hyperthermic intraper-
itoneal perfusion (IEPCHIP) in the treatment of peritoneal
carcinomatosis of gastric cancer. Thus, we conducted an
investigation of IEPCHIP in a swine model of experimen-
tal distal gastrectomy with Billroth II reconstruction to
examine the safety of this procedure at a temperature
range of 37 to 45°C.
Methods
This study was performed according to the principles of
the Declaration of Helsinki, and the institutional review
boards of the respective institutions reviewed and appro-
ved its design.
Model building and management
Thirty healthy and mature Bama Minipigs were used (15
females and 15 males). The animals were provided by the
mini pig incubator from Taizhou City, Jiangsu Province.
The average weight of these animals was 20 ± 2 kg.
All pigs were fasted for 12 h prior to surgery. The pro-
cedure was performed under intravenous and inhaled
anesthesia. The same team of surgeons performed all of
the procedures to ensure technical uniformity.
The Bama pigs were randomly divided into 5 groups.
Groups A1 and A2 served as the control groups, and
groups B, C and D represented the hyperthermic perfusion
groups. Pigs in group A1 underwent distal gastrectomy
with Billroth II reconstruction (Figure 1A). The other
groups received IEPCHIP after undergoing the same pro-
cedure as group A1.
Preoperatively, the abdomen was prepared by shaving.
After satisfactory anesthesia was achieved under sterile
conditions, we performed a distal stomach resection and
constructed a gastrojejunostomy and an end-to-end
jejunojejunostomy through a median incision using 3–0
silk sutures (Ethicon, Norderstedt, Germany). In groups
A2, B, C and D, two outflow catheters were placed be-
neath the diaphragm, and 2 inflow catheters were placed
in the pelvic cavity of each pig (Figure 1B). The catheters
were fixed to surrounding skin with 1–0 silk sutures
(Ethicon, Norderstedt, Germany). All skin incisions were
then sutured to close the abdomen.
The IEPCHIP procedure
The animals in groups A2, B, C and D were connected
to the hyperthermic intraperitoneal perfusion treatment
system (BR - TRG Type 1, Guangzhou Poris Medical
Technology Co., LTD, Guangzhou, China). The intrape-
ritoneal perfusion circuit was established with a constant
temperature, and dynamic temperature monitoring was
performed near the inflow and outflow catheters, the
anus and the mouth using electronic thermometers.
Figure 1 The procedure and postoperative adhesion. A, Enteroenterostomy. B, Hyperthermic perfusion in the swine model. C1 and C2, No
postoperative adhesion was observed in groups A2 and B. D1 and D2, Postoperative filmy and dense adhesion was observed in group D.
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outflow catheters in the abdominal cavity and were
attached to the heat exchanger to control the thermal
distribution. Through the path where the inflow and
outflow catheters enter the abdomen, all perfusion solu-
tions were monitored in real time by inserting a therm-
ometer into the abdomen to measure the temperature of
the perfusate. The perfusate of groups A2, B, C and D
were preheated to 37°C, 42.5°C, 43.5°C and 44.5°C, and
the water temperature difference between the inflow and
outflow catheters was controlled to a level ≤ 0.5°C. Thus,
the perfusion temperature in the peritoneal cavity was
maintained at 37 ± 0.5°C, 42.5 ± 0.5°C, 43.5 ± 0.5°C and
44.5 ± 0.5°C for groups A2, B, C and D, respectively. The
perfusion parameters included a perfusate volume of
2,500 ml saline and a flow rate 1.5 l/min. Each pig in
group A2 and the perfusion groups received 60 min of
perfusion, and the perfusions were performed twice. The
starting time for the first perfusion was when the surgery
was finished and the abdomen had been closed. The
second perfusion was initiated 1 day after the surgery.
We gently massaged the abdominal wall during perfu-
sion to equalize the distribution of the perfusion fluid.
After the perfusion, we used multiple bellybands to
provide protection to the abdominal incision. No pigs
received food for 24 h postoperatively, and all animals
were intravenously treated with 80,000 IU gentamicin
and 0.5 g metronidazole in a glucose and sodium chlo-
ride solution at a dose of 40 ml/kg. On the third day, a
no-slag liquid diet was administered, and on the sixth
day, the animals were given a semi-fluid diet and were
gradually transitioned to a normal diet. Postoperativeintraperitoneal hyperthermic perfusion was also perfor-
med in pigs under systemic anesthesia with their legs
fastened. Tramadol at 30 mg per day was administered
to relieve pain; this treatment was continued for 3
successive days after surgery.
Observed parameters
We measured respiratory frequency, blood pressure, anal
temperature and heart rate in the pigs 2 hours before,
during and 2 hours after the procedure. We also observed
the postoperative condition of the experimental animals,
including defecation, diet, activity and weight changes,
and we classified the performance of each animal after
surgery.
Peripheral venous blood was extracted from all of the
animals prior to surgery and 1 day, 3 days, 7 days and
14 days after the operation. Glutamic-pyruvic transami-
nase (ALT), albumin (ALB), total bilirubin (TBIL), blood
urea nitrogen (BUN) and creatinine (CR) levels were
evaluated.
The animals were sacrificed 14 days after the proce-
dure, at which time an autopsy was performed.
Measurement of anastomotic bursting pressure, breaking
strength and hydroxyproline content
After the anastomotic segments were cleared with saline,
the anastomotic bursting pressure and breaking strength
were measured. After cutting both ends of the anasto-
mosis, two catheters were inserted 3 cm from either side
of the anastomosis; then, two ligations were made 3 cm
proximal and distal to the anastomosis by using 1–0 silk
sutures. The catheters were connected to an infusion
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removed. Steady infusion with air allowed for a uniform
increase in the pressure at the anastigmatic site. The
pressure of mercury at the anastomotic site was increa-
sed by approximately 1 mmHg/sec. When the mercury
level did not rise or fall, the pressure reading was
recorded as the bursting pressure (mmHg), which re-
presents the peak intraluminal pressure just prior to
leakage. In addition, the fracture location was recorded.
The jejunum bursting pressures of normal adult pigs
were used as controls. Next, the ligation to the connec-
tion pipe was removed, and a longitudinal incision on
the anastomosis was made. One end of the resulting
anastomosis strip was fixed, and the other end was
attached to a spring. The tension was then increased in
0.098 N/s increments until the anastomosis broke. At
the breaking point, the tension was noted, and this
tension was defined as the breaking strength (kg).
Hydroxyproline provides an index of collagen concen-
tration, as it is the most common amino acid in collagen.
A chemical colorimetric method, with analytically pure
reagents, was used to calculate the hydroxyproline content
according to the following formula: hydroxyproline content
(μg/mg wet weight) = (absorbance of spectrophotometer
tube - blank tube absorbance/standard tube absorbance -
blank tube absorbance) × standard substance content
(5 μg/ml) × hydrolysate overall volume (10 ml) / wet weight
of organization (mg).
Pathological examination
The anastomotic tissue was excised and fixed in a 4%
formaldehyde solution by using routine and standard
procedures. Serial 5-μm sections of paraffin blocks were
prepared and stained with hematoxylin-eosin (HE). These
specimens were evaluated with light microscopy.Statistical analysis
All experimental data were analyzed with SPSS18.0
Statistical Software (SPSS Inc, Chicago, IL, USA). The data
concerning liver and kidney functions were expressed as
the means ± SD. Differences among the groups were
analyzed and compared using an analysis of variance and
the Newman-Keuls test. P values less than 0.05 were con-
sidered statistically significant.Results
No major complications occurred during the surgery or
the perfusion procedures.
Abdominal adhesion and anastomosis
Adhesion was not detected in groups A1, A2 (Figure 1, C1)
or B (Figure 1, C2). Only 1 case with membranous adhe-
sion was observed in group C. Membranous adhesion anddense adhesion were observed in 3 pigs in group D
(Figure 1D1, D2).
The average bursting pressure, breaking strength and
hydroxyproline content of the stomach-jejunum anasto-
mosis and jejunum-jejunum anastomosis in groups C
and D were less than those values observed in groups
A1, A2 and B (Figure 2).
Pathology
Collagen fiber formation inside the anastomosis was
visible following HE staining. Compared with that of
groups B, C and D, collagen was more densely deposited
in the anastomosis of groups A1 and A2, with better
granulation and tissue formation, and the repair of the
mucous layer was superior in the 2 groups (Figure 3, A1
and A2). In group B, collagen deposition was dense in the
anastomosis (Figure 3B), and irregular collagen deposition
was present in smaller quantities in group C than in group
B (Figure 3C). Collagen deposition was least dense in
group D and was accompanied by inflammatory cell infil-
tration (Figure 3D).
Perioperative vital signs
Compared to the values obtained prior to perfusion, the
body temperature of the pigs in groups A1 and A2 was
stable, as were the heart rates, respiratory rates and mean
arterial pressures during the procedure. In addition, after
perfusion of the animals in groups B and C, the body
temperatures increased by an average of approximately
1°C, the heart rate increased to an average of 105 beats
per min, the respiratory rate increased to 35 times per
min, and the mean arterial pressure decreased by approxi-
mately 25 mmHg. Two hours after the procedure, the vital
signs reached normal levels in these animals. In group D,
the average temperature rose by 1.5°C, the heart rate
increased to approximately 120 beats per min, the respira-
tory rate rose to 40 times per min, and the mean arterial
pressure decreased by approximately 35 mmHg. The vital
signs of these animals did not return to normal levels
within 2 h of the procedure.
Postoperative recovery
All pigs were prone for most of the first day. All of the
pigs in groups A1, A2, B and C were able to stand and
walk 1 day after the procedure. After 2 days, the animals
were able to drink and eat. After the procedure, only 1
pig in group C vomited twice on the first day. Further-
more, the mental status and performance status of the
animals were fair. However, the animals in group D were
unable to stand on the day after the procedure, and
three pigs groaned continuously. Two days later, the
animals could only drink, but on the third day, these pigs
began eating. In group D, one pig experienced vomiting 2
Figure 2 Three charts depicting measurements of wound healing. Chart 1, Measurement results for bursting pressure. The bursting pressures
of the stomach jejunum anastomosis and the jejunum-jejunum anastomosis were not significantly different between animals in group B and
group A (P > 0.05). The bursting pressure of the anastomosis was significantly different for animals in groups C and D (P < 0.05) as compared to
groups A1 and A2. Chart 2, Measurement results for breaking strength. The breaking strength of the stomach jejunum anastomosis and the
jejunum-jejunum anastomosis was not significantly different between animals in group B and groups A1 and A2 (P > 0.05). The breaking strength
of the anastomosis was significantly different for the animals in groups C and D (P < 0.05) as compared to groups A1 and A2. Chart 3, Results of
hydroxyproline content measurements. The hydroxyproline content of the stomach jejunum anastomosis and the jejunum anastomosis was not
significantly different between animals in group B and groups A1 and A2 (P > 0.05). The hydroxyproline content of the anastomosis was
significantly different for animals in groups C and D (P < 0.05) as compared to groups A1 and A2.
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for 3 successive days.
Liver and renal function
The levels of ALT, TBIL and ALB in the pigs in groups
A1 and A2 remained stable. At perfusion temperaturesof 37 ± 0.5°C, 42.5 ± 0.5°C and 43.5 ± 0.5°C, a 60-min
continuous hyperthermic intraperitoneal perfusion had
no significant influence on liver or kidney function. After
1 week, the group A1 and A2 pigs had recovered to
normal levels. In contrast, at a temperature of 44.5 ± 0.5°C,
a 60-min continuous hyperthermic intraperitoneal perfu-
Figure 3 Pathological examination of anastomotic tissue. A1 and A2, Collagen was deposited densely in the anastomosis, with better repair
of the mucous layer in groups A1 and A2. B, Collagen was deposited densely in the anastomosis of group B animals. C, Reduced and irregular
collagen deposition was observed in the anastomosis of group C animals. D, Reduced and irregular collagen deposition and inflammatory cells
infiltration was observed in the anastomosis of group D animals.
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functions. This impairment in kidney and liver function
lasted for at least 2 weeks. Parameters related to liver and
renal functions are shown in Tables 1, 2 and 3 for the pigs
in groups B, C and D.
Discussion
Intraoperative hyperthermic intraperitoneal chemotherapy
(IHIC) alone and IHIC combined with early postoperative
intraperitoneal chemotherapy have been performed in
previous studies [10,26-28]. Improved survival has been
reported in these studies, albeit with certain levels of
mortality and severe complications [11,29]. The goal ofTable 1 Changes in the liver and renal function of the pigs in
Before the perfusion
1 d 3 d
ALT 65.65 ± 5.34 70.65 ± 4.11★ 78.65 ± 4.75■
TBIL 8.53 ± 1.01 10.12 ± 2.23★ 17.36 ± 3.32■
ALB 30.01 ± 2.47 29.02 ± 1.13★ 25.83 ± 1.42■
CR 58.12 ± 5.24 60.72 ± 4.01★ 64.49 ± 5.06★
BUN 4.59 ± 1.79 4.98 ± 2.34★ 7.29 ± 1.05★
ALT Alanine aminotransferase, TBIL Serum total bilirubin, ALB Albumin, CR CreatinineIEPCHIP is to kill free cancer cells and remove micro
lesions at an early time after cytoreductive surgery.
During the perfusion process, the vital signs of the
animals studied varied across the perfusion groups. The
pigs in groups A1, A2, B and C recovered quickly and
ate and drank sooner after surgery, than the pigs in
group D. As demonstrated above, the 44.5 ± 0.5°C perfu-
sate had a significant and lasting impact on the animals’
vital signs and diet.
The liver can also be affected by anesthesia and hyper-
thermic intraperitoneal chemotherapy. In one previous
study, the hepatic and renal functions of mice in a hy-
perthermic intraperitoneal chemotherapy group treated atgroup B
After the perfusion
5 d 7 d 14 d
98.45 ± 3.64■ 71.48 ± 5.35★ 63.29 ± 4.58★
11.75 ± 3.79★ 10.19 ± 3.42★ 9.87 ± 1.44★
26.91 ± 2.35★ 29.42 ± 2.34★ 30.02 ± 1.23★
69.92 ± 2.45■ 63.76 ± 6.01★ 59.12 ± 3.19★
10.02 ± 1.14■ 7.09 ± 2.23★ 5.03 ± 2.21★
, BUN Blood urea nitrogen.
Table 2 Changes in the liver and renal function of the pigs in group C
Before the perfusion After the perfusion
1 d 3 d 5 d 7 d 14 d
ALT 66.24 ± 5.40 71.32 ± 2.32★ 80.11 ± 4.26■ 102.31 ± 3.23■ 72.35 ± 6.19★ 68.71 ± 3.23★
TBIL 8.45 ± 0.94 11.1 ± 03.02★ 15.45 ± 2.19■ 18.75 ± 1.08■ 11.65 ± 4.01★ 10.09 ± 2.13★
ALB 29.34 ± 2.23 28.19 ± 3.41★ 27.43 ± 2.10★ 26.39 ± 4.02★ 28.39 ± 3.05★ 29.33 ± 1.92★
CR 57.73 ± 5.48 61.45 ± 3.76★ 65.34 ± 6.51★ 70.24 ± 4.19■ 64.95 ± 5.59★ 60.23 ± 4.76★
BUN 4.58 ± 1.83 5.02 ± 1.45★ 7.31 ± 2.97★ 9.65 ± 1.75■ 8.63 ± 2.12■ 5.12 ± 1.39★
ALT Alanine aminotransferase, TBIL Serum total bilirubin, ALB Albumin, CR Creatinine, BUN Blood urea nitrogen.
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rature group receiving an application of a paclitaxel and
beta-cyclodextrin formulation [30]. In these studies, heat
stress was thought to cause the liver damage, which was
aggravated over time and was thought to arise from a
series of complex oxidative stress responses [31]. In the
present experiment, the changes in hepatic and renal func-
tion in groups A2, B and C were reversible. Perfusion at
37 ± 0.5°C, 42.5 ± 0.5 and 43.5 ± 0.5°C also caused related
physiological parameters to rise transiently and mildly.
Nevertheless, perfusion at 44.5 ± 0.5°C cased these para-
meters to change substantially, resulting in apparent
hepatic and renal dysfunction. The 2 perfusions performed
at 44.5 ± 0.5°C induced a lasting and obvious impairment
to liver and renal functions.
After hyperthermic intraperitoneal chemotherapy, 4%
of a group of patients with gynecological cancer deve-
loped intestinal obstruction due to intestinal adhesion
[32], and the majority of these obstructions were related
to intra-abdominal tumor progression. Intestinal obstruc-
tion may be even more common after surgery and hyper-
thermic intraperitoneal chemotherapy for gastrointestinal
cancer. In the current study, abdominal adhesion was not
observed in groups A1, A2 and B and was considered mild
in group C. However, perfusion at 44.5 ± 0.5°C induced
severe adhesion. This level of hyperthermia likely dama-
ged the gastrointestinal serous and parietal peritoneum,
which led to the secretion of inflammatory substances and
fibrous proteins and the formation of abdominal adhesion.
A low average anastomotic bursting pressure and breaking
strength has been shown to be indicative of poor anas-Table 3 Changes in the liver and renal function of the pigs in
Before the perfusion
1 d 3 d
ALT 65.98 ± 4.90 70.32 ± 3.90★ 76.45 ± 5.18■
TBIL 8.39 ± 0.87 12.03 ± 0.87■ 22.42 ± 1.12■
ALB 30.02 ± 2.14 29.12 ± 1.90★ 28.07 ± 1.23★
CR 57.43 ± 5.28 68.23 ± 5.12■ 79.24 ± 6.23■
BUN 4.66 ± 1.79 8.03 ± 1.32■ 9.23 ± 2.03■
Notes: in comparison to the values obtained prior to perfusion, ★ = no significant d
ALT Alanine aminotransferase, TBIL Serum total bilirubin, ALB Albumin, CR Creatininetomosis healing [20,33]. Aarts et al. [34] found that in
comparison to cytoreductive surgery alone, mice receiving
cytoreductive surgery plus hyperthermic intraperitoneal
chemotherapy appeared to have a significant decline in
the average anastomotic bursting pressure of the gastro-
intestinal tract. However, in the present study, there was
no intestinal obstruction or anastomotic leakage observed
in any of the pigs.
Although no obvious anastomotic leakage occurred, the
anastomotic bursting pressure and breaking strength
declined gradually with the rise of the perfusion tempe-
rature. Particularly, when the perfusion temperature was
43.5 ± 0.5°C or higher, these 2 parameters were signifi-
cantly lower than those observed in groups A1 and A2.
Compared to groups A1 and A2, the hydroxyproline
content in the stomas of the perfusion groups decreased,
and this effect was significant when compared to the
effects of 43.5 ± 0.5°C perfusion. Nevertheless, neither the
average anastomotic bursting pressure nor the hydroxy-
proline content of group B was lower than that observed
in the control groups. This result suggests that perfusion
at 42.5 ± 0.5°C does not increase the risk of anastomotic
leakage. As demonstrated above, hyperthermal perfusion
may inhibit collagen deposition in the stomas and thus
reduce the tensile strength. Compact collagen deposition
developed in the anastomosis of groups A1, A2 and B,
with the former group displaying improved bud organi-
zation and repair of mucous membranes. Following the
rise of the perfusion temperature, the ability of collage-
nous fiber formation was weakened by the reduced and
irregular collagen deposition. Furthermore, inflammatorygroup D
After the perfusion
5 d 7 d 14 d
89.65 ± 4.23■ 95.27 ± 6.03■ 84.72 ± 5.03■
20.63 ± 1.43■ 14.23 ± 2.01■ 10.12 ± 1.90★
27.34 ± 2.17★ 25.54 ± 1.47■ 24.35 ± 1.59■
88.47 ± 4.09■ 80.92 ± 5.35■ 70.22 ± 4.01■
10.12 ± 1.92■ 9.04 ± 1.97■ 8.64 ± 2.24■
ifference(P > 0.05) and ■ = significant difference (P < 0.05).
, BUN Blood urea nitrogen.
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Together, these results demonstrated the inhibition of
both the formation of collagenous fiber and anastomotic
healing.
Although perfusion using the open technique is believed
to provide optimal thermal homogeneity and homoge-
neous distribution of chemotherapy in a swine model of
IEPCHIP, we performed a closed technique intraopera-
tively for the following reasons. First, our machine was a
closed system, which is suitable for the maintenance of a
stable temperature, and the perfusion temperature may
decrease at a greater rate in an open environment
perfusion. Also, a closed HIPEC was used to reduce the
difference in the temperature between the inflow and
outflow. Second, the closed technique achieved higher
temperatures within the diaphragmatic area, while the
open technique has been shown to result in higher
temperatures in the mid and lower abdomen [35]. Most
gastric cancers reside between the diaphragmatic area and
the middle abdomen, where higher temperatures are
achieved with the closed technique. Third, we gently
massaged the abdominal wall during the perfusion, which
made the distribution of the perfusion fluid and heat
conduction equal. Fourth, operator exposure to chemo-
therapeutic agents and environmental pollution must be
considered with the open technique [36]. Fifth, the time of
general anesthesia is extended for the open technique,
which may increase the risk of the associated surgery.
The efficacy and safety of intraperitoneal hyperthermic
perfusion chemotherapy are influenced by the following
factors [37]: the dose and concentration of the chemo-
therapy used; the intraperitoneal perfusion temperature
and duration; the perfusion times and the osmotic
pressure of the treatment fluid. Currently, no large-scale
multicenter randomized controlled trials examining
different chemotherapy schemes and different combina-
tions of hyperthermia and chemotherapy have been
completed to determine the best chemotherapy scheme
for peritoneal carcinomatosis of gastric cancer, specifi-
cally in Asian populations. The design of such a study is
very complex, as it must fully simulate the combined
effect of different temperatures and different commonly
used chemotherapeutic agents. However, after evaluating
appropriate perfusion temperatures and the optimal
scheme of chemotherapy, we should be able to construct
a better model of perfusion and fully evaluate the clinical
effects. This approach would also save animals and
reduce their suffering. Initially, it is important to focus
on the appropriate perfusion temperature in the absence
of chemotherapy, as suitable temperatures are the basis
of these studies and their clinical transformation.
Furthermore, efficacy studies should be performed with
acceptable complications using a certain temperature; for
example, because a perfusion temperature higher than42.5 ± 0.5°C with or without chemotherapy was able to kill
free cancer cells, the safety of perfusion at different
temperatures should be considered.
As the survival rates have improved after cytoreductive
surgery plus IEPCHIP for gastric cancer, the toxicity of
additional chemotherapy should be monitored closely.
In a meta-analysis of randomized controlled trials on
hyperthermic intraperitoneal chemotherapy for resec-
table gastric cancer, the postoperative mortality rates of
6 trials were 2.6% (10/385) [11]. In a multi-institutional
study of 1,290 patients that examined the treatment of
peritoneal carcinomatosis of non-ovarian origin by
cytoreductive surgery and perioperative intraperitoneal
chemotherapy, the mortality rate was 4.1% [28]. In
another multi-institutional study examining cytoreductive
surgery combined with intraoperative and postoperative
intraperitoneal chemotherapy for peritoneal carcinoma-
tosis from colorectal cancer, the related mortality rate was
reported to be 4% (20/506) [29].
Additional chemotherapy may be excessively risky for
these patients, and the possible increase in cancer stem
cell number after chemotherapy is of further concern
[38]. Hyperthermic perfusion can also be effective,
allowing a better quality of life without some of the com-
plications observed after procedures for advanced gastric
cancer. Besides, cytoreductive surgery with hyperthermic
intraperitoneal chemotherapy prolongs survival at consi-
derable morbidity and mortality in elderly patients [39].
Hyperthermic intraperitoneal perfusion without chemo-
therapy may be especially suitable for elderly patients with
a poor performance status or those who cannot tolerate
chemotherapy. Therefore, we performed intraoperative
and early postoperative continuous hyperthermic intrape-
ritoneal perfusion without chemotherapy on 34 patients
with advanced gastric cancer since 2011.
For the above-mentioned reasons, the current study
focused on determining the acceptable temperature
range, which is the basis of hyperthermic intraperitoneal
perfusion with or without chemotherapy.Conclusions
We found that IEPCHIP at 42.5 ± 0.5°C did not signifi-
cantly harm the recipient pigs in terms of their vital signs,
liver function, renal function and anastomotic healing.
Furthermore, there was no added risk of anastomotic leak-
age and abdominal adhesion. Thus, perfusion at 42.5 ±
0.5°C was safe and appropriate for IEPCHIP, whereas
perfusion at 43.5 ± 0.5°C or 44.5 ± 0.5°C was harmful and
shown to significantly worsen anastomotic healing.
Abbreviations
IEPCHIP: Intraoperative and early postoperative continuous hyperthermic
intraperitoneal perfusion; ALT: Glutamic-pyruvic transaminase; TBIL: Total
bilirubin; ALB: albumin; CR: Creatinine; BUN: Blood urea nitrogen.
Li et al. Journal of Translational Medicine 2013, 11:181 Page 9 of 10
http://www.translational-medicine.com/content/11/1/181Competing interests
The authors declare no competing interests.
Authors’ contributions
SL and YZ contributed equally to this study. YH and PW are both
corresponding authors and they conceived, designed and partially
conducted the study; these authors also played a major role in the revision
of the manuscript. SL participated in the design of the study and performed
the statistical analyses; SL and YZ helped to conduct the study and draft the
manuscript; JS provided technical support and was involved in the drafting
of the manuscript. All authors read and approved the final manuscript.
Acknowledgments
This study was supported by funding from Natural Science Foundation of
China. No: 81172165.
Author details
1State Key Laboratory of Oncology in South China, 510060, Guangzhou,
Guangdong, P.R China. 2Department of Medical Imaging & Interventional
Radiology, Sun Yat-sen University Cancer Center, 510060, Guangzhou,
Guangdong, P.R China. 3Henan Province Cancer Hospital, Guangzhou, P.R
China. 4Department of Radiotherapy, Sun Yat-sen University Cancer Center,
510060, Guangzhou, Guangdong, P.R China.
Received: 28 January 2013 Accepted: 24 July 2013
Published: 29 July 2013
References
1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer
statistics. CA Cancer J Clin 2011, 61:69–90.
2. Al-Shammaa HA, Li Y, Yonemura Y: Current status and future strategies of
cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy
for peritoneal carcinomatosis. World J Gastroenterol 2008, 14:1159–1166.
3. Roviello F, Caruso S, Marrelli D, Pedrazzani C, Neri A, De Stefano A, Pinto E:
Treatment of peritoneal carcinomatosis with cytoreductive surgery and
hyperthermic intraperitoneal chemotherapy: state of the art and future
developments. Surg Oncol 2011, 20:e38–e54.
4. Yonemura Y, Kawamura T, Bandou E, Tsukiyama G, Endou Y, Miura M: The
natural history of free cancer cells in the peritoneal cavity. Recent Results
Cancer Res 2007, 169:11–23.
5. Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, Zhou YF, Xiong B,
Yonemura Y, Li Y: Cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy improves survival of patients with
peritoneal carcinomatosis from gastric cancer: final results of a phase III
randomized clinical trial. Ann Surg Oncol 2011, 18:1575–1581.
6. Yonemura Y, Fujimura T, Nishimura G, Falla R, Sawa T, Katayama K, Tsugawa
K, Fushida S, Miyazaki I, Tanaka M, et al: Effects of intraoperative
chemohyperthermia in patients with gastric cancer with peritoneal
dissemination. Surgery 1996, 119:437–444.
7. Tang L, Mei LJ, Yang XJ, Huang CQ, Zhou YF, Yonemura Y, Li Y:
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy
improves survival of gastric cancer with peritoneal carcinomatosis:
evidence from an experimental study. J Transl Med 2011, 9:53.
8. Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B, Bereder JM,
Lorimier G, Quenet F, Elias D: Peritoneal carcinomatosis from gastric
cancer: a multi-institutional study of 159 patients treated by
cytoreductive surgery combined with perioperative intraperitoneal
chemotherapy. Ann Surg Oncol 2010, 17:2370–2377.
9. Esquivel J, Sticca R, Sugarbaker P, Levine E, Yan TD, Alexander R, Baratti D,
Bartlett D, Barone R, Barrios P, et al: Cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy in the management of peritoneal surface
malignancies of colonic origin: a consensus statement. Society of Surgical
Oncology. Ann Surg Oncol 2007, 14:128–133.
10. Klaver YL, Hendriks T, Lomme RM, Rutten HJ, Bleichrodt RP, De Hingh IH:
Intraoperative versus early postoperative intraperitoneal chemotherapy
after cytoreduction for colorectal peritoneal carcinomatosis: an
experimental study. Ann Surg Oncol 2012, 19(Suppl 3):S475–S482.
11. Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, Morris DL: A
systematic review and meta-analysis of the randomized controlled trials
on adjuvant intraperitoneal chemotherapy for resectable gastric cancer.
Ann Surg Oncol 2007, 14:2702–2713.12. Brucher BL, Piso P, Verwaal V, Esquivel J, Derraco M, Yonemura Y, Gonzalez-
Moreno S, Pelz J, Konigsrainer A, Strohlein M, et al: Peritoneal
carcinomatosis: cytoreductive surgery and HIPEC–overview and basics.
Cancer Invest 2012, 30:209–224.
13. Uzunkoy A, Bolukbas C, Horoz M, Bolukbas FF, Kocyigit A: The optimal
starting time of postoperative intraperitoneal mitomycin-C therapy with
preserved intestinal wound healing. BMC Cancer 2005, 5:31.
14. Khatri VP: Cytoreductive surgery and hyperthermic intraperitoneal
chemotherapy for colorectal cancer: a panacea or just an obstacle
course for the patient? J Clin Oncol 2010, 28:5–7.
15. Kusamura S, Baratti D, Deraco M: Multidimensional analysis of the learning
curve for cytoreductive surgery and hyperthermic intraperitoneal
chemotherapy in peritoneal surface malignancies. Ann Surg 2012,
255:348–356.
16. Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, Deraco M:
Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion:
analysis of morbidity and mortality in 209 peritoneal surface malignancies
treated with closed abdomen technique. Cancer 2006, 106:1144–1153.
17. Verwaal VJ, Van Tinteren H, Ruth SV, Zoetmulder FA: Toxicity of
cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy.
J Surg Oncol 2004, 85:61–67.
18. Kusamura S, Baratti D, Antonucci A, Younan R, Laterza B, Oliva GD, Gavazzi
C, Deraco M: Incidence of postoperative pancreatic fistula and
hyperamylasemia after cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy. Ann Surg Oncol 2007, 14:3443–3452.
19. Tsilimparis N, Bockelmann C, Raue W, Menenakos C, Perez S, Rau B,
Hartmann J: Quality of life in patients after cytoreductive surgery and
hyperthermic intraperitoneal chemotherapy: is it worth the risk?
Ann Surg Oncol 2013, 20:226–232.
20. El-Malt M, Ceelen W, Van den Broecke C, Cuvelier C, Van Belle S, De
Hemptinne B, Pattyn P: Influence of neo-adjuvant chemotherapy with
5-fluorouracil on colonic anastomotic healing: experimental study in
rats. Acta Chir Belg 2003, 103:309–314.
21. Smeenk RM, Verwaal VJ, Zoetmulder FA: Toxicity and mortality of
cytoreduction and intraoperative hyperthermic intraperitoneal
chemotherapy in pseudomyxoma peritonei–a report of 103 procedures.
Eur J Surg Oncol 2006, 32:186–190.
22. Van der Speeten K, Stuart OA, Sugarbaker PH: Pharmacokinetics and
pharmacodynamics of perioperative cancer chemotherapy in peritoneal
surface malignancy. Cancer J 2009, 15:216–224.
23. Sugarbaker PH: Observations concerning cancer spread within the
peritoneal cavity and concepts supporting an ordered pathophysiology.
Cancer Treat Res 1996, 82:79–100.
24. Murray TG, Cicciarelli N, McCabe CM, Ksander B, Feuer W, Schiffman J, Mieler
WF, O’Brien JM: In vitro efficacy of carboplatin and hyperthermia in a
murine retinoblastoma cell line. Invest Ophthalmol Vis Sci 1997, 38:2516–2522.
25. Klaver YL, Hendriks T, Lomme RM, Rutten HJ, Bleichrodt RP, De Hingh IH:
Hyperthermia and intraperitoneal chemotherapy for the treatment of
peritoneal carcinomatosis: an experimental study. Ann Surg 2011,
254:125–130.
26. Deng HJ, Wei ZG, Zhen L, Li GX, Uang XC, Qing SH: Clinical application of
perioperative continuous hyperthermic peritoneal perfusion chemotherapy
for gastric cancer. Nan Fang Yi Ke Da Xue Xue Bao 2009, 29:295–297.
27. Jacquet P, Averbach A, Stephens AD, Stuart OA, Chang D, Sugarbaker PH:
Heated intraoperative intraperitoneal mitomycin C and early
postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies.
Oncology 1998, 55:130–138.
28. Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, Mansvelt B,
Lorimier G, Msika S, Elias D: Toward curative treatment of peritoneal
carcinomatosis from nonovarian origin by cytoreductive surgery
combined with perioperative intraperitoneal chemotherapy: a multi-
institutional study of 1,290 patients. Cancer 2010, 116:5608–5618.
29. Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M,
Barone R, Yonemura Y, Cavaliere F, Quenet F, et al: Cytoreductive surgery
combined with perioperative intraperitoneal chemotherapy for the
management of peritoneal carcinomatosis from colorectal cancer: a
multi-institutional study. J Clin Oncol 2004, 22:3284–3292.
30. Bouquet W, Ceelen W, Adriaens E, Almeida A, Quinten T, De Vos F, Pattyn P,
Peeters M, Remon JP, Vervaet C: In vivo toxicity and bioavailability of
Taxol and a paclitaxel/beta-cyclodextrin formulation in a rat model
during HIPEC. Ann Surg Oncol 2010, 17:2510–2517.
Li et al. Journal of Translational Medicine 2013, 11:181 Page 10 of 10
http://www.translational-medicine.com/content/11/1/18131. Das A: Heat stress-induced hepatotoxicity and its prevention by
resveratrol in rats. Toxicol Mech Methods 2011, 21:393–399.
32. Kehoe SM, Williams NL, Yakubu R, Levine DA, Chi DS, Sabbatini PJ,
Aghajanian CA, Barakat RR, Abu-Rustum NR: Incidence of intestinal
obstruction following intraperitoneal chemotherapy for ovarian tubal
and peritoneal malignancies. Gynecol Oncol 2009, 113:228–232.
33. Yamaguchi R, Terashima H, Yoneyama S, Tadano S, Ohkohchi N: Effects of
platelet-rich plasma on intestinal anastomotic healing in rats: PRP
concentration is a key factor. J Surg Res 2012, 173:258–266.
34. Aarts F, Bleichrodt RP, De Man B, Lomme R, Boerman OC, Hendriks T: The
effects of adjuvant experimental radioimmunotherapy and hyperthermic
intraperitoneal chemotherapy on intestinal and abdominal healing
after cytoreductive surgery for peritoneal carcinomatosis in the rat.
Ann Surg Oncol 2008, 15:3299–3307.
35. Ortega-Deballon P, Facy O, Jambet S, Magnin G, Cotte E, Beltramo JL,
Chauffert B, Rat P: Which method to deliver hyperthermic intraperitoneal
chemotherapy with oxaliplatin? An experimental comparison of open
and closed techniques. Ann Surg Oncol 2010, 17:1957–1963.
36. Simon L, Halilou MC, Gladieff L, Gadiou M, Herin F, Hennebelle I, Chatelut E,
Ferron G: Hyperthermic intraoperative intraperitoneal chemotherapy
(HIPEC): evaluation, prevention and policies to avoid occupational
exposure for operating room personnel. Bull Cancer 2009, 96:971–977.
37. Kusamura S, Dominique E, Baratti D, Younan R, Deraco M: Drugs, carrier
solutions and temperature in hyperthermic intraperitoneal
chemotherapy. J Surg Oncol 2008, 98:247–252.
38. Dylla SJ, Beviglia L, Park IK, Chartier C, Raval J, Ngan L, Pickell K, Aguilar J,
Lazetic S, Smith-Berdan S, et al: Colorectal cancer stem cells are enriched
in xenogeneic tumors following chemotherapy. PLoS One 2008, 3:e2428.
39. Votanopoulos KI, Newman NA, Russell G, Ihemelandu C, Shen P, Stewart JH,
Levine EA: Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic
Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years;
Survival Benefit at Considerable Morbidity and Mortality. Ann Surg Oncol 2013.
doi:10.1186/1479-5876-11-181
Cite this article as: Li et al.: Safe temperature range for intraoperative
and early postoperative continuous hyperthermic intraperitoneal
perfusion in a swine model of experimental distal gastrectomy with
Billroth II reconstruction. Journal of Translational Medicine 2013 11:181.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
